Unknown

Dataset Information

0

Leveraging mRNA Sequences and Nanoparticles to Deliver SARS-CoV-2 Antigens In Vivo.


ABSTRACT: SARS-CoV-2 has become a pandemic worldwide; therefore, an effective vaccine is urgently needed. Recently, messenger RNAs (mRNAs) have emerged as a promising platform for vaccination. In this work, the untranslated regions (UTRs) of mRNAs are systematically engineered in order to enhance protein production. Through a comprehensive analysis of endogenous gene expression and de novo design of UTRs, the optimal combination of 5' and 3' UTR are identified and termed NASAR, which are 5- to 10-fold more efficient than the tested endogenous UTRs. More importantly, NASAR mRNAs delivered by lipid-derived TT3 nanoparticles trigger a dramatic expression of potential SARS-CoV-2 antigens. The antigen-specific antibodies induced by TT3-nanoparticles and NASAR mRNAs are over two orders of magnitude more than that induced by the FDA-approved lipid nanoparticle material MC3 in vaccinated mice. These NASAR mRNAs merit further development as alternative SARS-CoV-2 vaccines.

SUBMITTER: Zeng C 

PROVIDER: S-EPMC8191860 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9376583 | biostudies-literature
| S-EPMC7974401 | biostudies-literature
| S-EPMC8733122 | biostudies-literature
| S-EPMC10131815 | biostudies-literature
| S-BSST379 | biostudies-other
| S-EPMC11307291 | biostudies-literature
| S-SCDT-10_1038-S44319-024-00216-4 | biostudies-other
| S-EPMC9791794 | biostudies-literature
| S-EPMC6445717 | biostudies-literature
| S-EPMC6909218 | biostudies-literature